17 | NociceptinIBA
11/2021
-
01/2011 |
9 | LigandsIBA
01/2022
-
05/2009 |
9 | Opioid Receptors (Opioid Receptor)IBA
11/2021
-
12/2009 |
7 | Opioid Analgesics (Opioids)IBA
01/2022
-
05/2009 |
5 | Nociceptin ReceptorIBA
12/2020
-
12/2009 |
4 | Levodopa (L Dopa)FDA LinkGeneric
11/2021
-
01/2018 |
4 | Opioid Peptides (Opioid Peptide)IBA
01/2021
-
01/2018 |
4 | mu Opioid Receptors (mu Opioid Receptor)IBA
11/2020
-
12/2009 |
4 | NicotineFDA Link
01/2020
-
10/2015 |
4 | Analgesics (Analgesic Drugs)IBA
12/2015
-
12/2009 |
4 | Morphine (MS Contin)FDA LinkGeneric
12/2015
-
05/2009 |
3 | at-403IBA
01/2022
-
01/2018 |
3 | Peptides (Polypeptides)IBA
11/2021
-
08/2020 |
3 | Buprenorphine (Subutex)FDA LinkGeneric
01/2018
-
03/2011 |
3 | Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2017
-
03/2015 |
3 | larazotide acetateIBA
10/2015
-
04/2015 |
3 | Messenger RNA (mRNA)IBA
03/2010
-
01/2005 |
2 | GTP-Binding Proteins (G-Protein)IBA
01/2022
-
11/2021 |
2 | NeuropeptidesIBA
01/2020
-
05/2016 |
2 | Cocaine (Cocaine HCl)IBA
10/2015
-
03/2011 |
2 | 2- (N- cyclopropylmethyl- 4,5- epoxy- 6,14- ethano- 3- hydroxy- 6- methoxymorphinan- 7- yl)- 3,3- dimethylpentan- 2- olIBA
07/2013
-
03/2011 |
2 | SR 14150IBA
11/2011
-
05/2009 |
2 | Hormones (Hormone)IBA
03/2010
-
12/2007 |
2 | EnzymesIBA
12/2007
-
01/2003 |
2 | epigallocatechin gallate (epigallocatechin-3-gallate)IBA
03/2006
-
01/2005 |
2 | TeaIBA
03/2006
-
01/2005 |
1 | 6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA
01/2022 |
1 | Oxidopamine (6 Hydroxydopamine)IBA
11/2021 |
1 | Methylphenidate (Ritalin)FDA LinkGeneric
08/2020 |
1 | cis- 1- methyl- 7- ((4- (2,6- dichlorophenyl)piperidin- 1- yl)methyl)- 6,7,8,9- tetrahydro- 5H- benzocyclohepten- 5- olIBA
10/2019 |
1 | Pharmaceutical PreparationsIBA
10/2019 |
1 | Explosive Agents (Explosives)IBA
01/2019 |
1 | Dopamine (Intropin)FDA LinkGeneric
05/2016 |
1 | Varenicline (Chantix)FDA Link
04/2015 |
1 | 8- (bis(2- methylphenyl)methyl)- 3- phenyl- 8- azabicyclo(3.2.1)octan- 3- olIBA
07/2013 |
1 | 1- (1- (2,3,3alpha,4,5,6- hexahydro- 1H- phenalen- 1- yl)piperidin- 4- yl)indolin- 2- oneIBA
07/2013 |
1 | Peptide Receptors (Peptide Receptor)IBA
07/2013 |
1 | Ion Channels (Ion Channel)IBA
03/2013 |
1 | MentholFDA Link
03/2013 |
1 | DNA (Deoxyribonucleic Acid)IBA
12/2011 |
1 | matrigelIBA
03/2010 |
1 | Proteins (Proteins, Gene)FDA Link
03/2010 |
1 | Tissue Inhibitor of Metalloproteinase-2IBA
03/2010 |
1 | SR 13179IBA
03/2010 |
1 | Matrix Metalloproteinase 2 (Gelatinase A)IBA
03/2010 |
1 | Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
07/2009 |
1 | Cell Cycle ProteinsIBA
07/2009 |
1 | Cyclin-Dependent Kinases (cdk Proteins)IBA
07/2009 |
1 | SR13904IBA
07/2009 |
1 | PPAR deltaIBA
07/2009 |
1 | Cyclin AIBA
07/2009 |
1 | 21- (2- N,N- diethylaminoethyl)oxy- 7- methyl- 19- norpregna- 1,3,5(10)- triene- 3- O- sulfamateIBA
12/2007 |
1 | SteroidsIBA
12/2007 |
1 | Selective Estrogen Receptor Modulators (SERM)IBA
12/2007 |
1 | Estrogen Receptor Modulators (Antiestrogen)IBA
12/2007 |
1 | Steryl-Sulfatase (Steroid Sulfatase)IBA
12/2007 |
1 | Estrogen Receptor alphaIBA
12/2007 |
1 | Catechin (Z 7300)IBA
03/2006 |